iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.190
-0.010 (-0.83%)
Sep 15, 2026, 2:10 PM EDT - Market open
iBio, Inc. Employees
iBio, Inc. had 23 employees as of June 30, 2026. The number of employees increased by 3 or 15.00% compared to the previous year.
Employees
23
Change (1Y)
3
Growth (1Y)
15.00%
Revenue / Employee
$4,348
Profits / Employee
-$1,436,696
Market Cap
76.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 23 | 3 | 15.00% | 23 | 0 |
| Jun 30, 2025 | 20 | 4 | 25.00% | 20 | 0 |
| Jun 30, 2024 | 16 | -10 | -38.46% | 16 | 0 |
| Jun 30, 2023 | 26 | -80 | -75.47% | 26 | 0 |
| Jun 30, 2022 | 106 | 31 | 41.33% | 105 | 1 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gain Therapeutics | 21 |
| RenovoRx | 17 |
| Cingulate | 14 |
| MAIA Biotechnology | 13 |
| Alterity Therapeutics | 11 |
| Aldeyra Therapeutics | 6 |
| OS Therapies | 5 |
| OKYO Pharma | 5 |
IBIO News
- 6 days ago - iBio, Inc. Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 11 days ago - iBio, Inc. Proxy statement: Proxy filing - Filings
- 13 days ago - iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference - GlobeNewsWire
- 18 days ago - iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 18 days ago - iBio, Inc. Annual report: Q4 2026 - Filings
- 18 days ago - iBio, Inc. Earnings release: Q4 2026 - Filings
- 26 days ago - iBio, Inc. Proxy statement: Proxy filing - Filings
- 6 weeks ago - iBio appoints Molly Carr as chief medical officer - TheFly